Finance

Lists
1720:TPE
Standard Chem & Pharm Co Ltd
NT$55,90
+0,18%
(+0,10) 1D
6 Okt., 13:30:00 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1720...
Open
NT$55,70
High
NT$56,20
Low
NT$55,70
Mkt. cap
10,99 mjd
Avg. vol.
176,91 k
Volume
114,65 k
Dividend
3,25%
Quarterly dividend
NT$0,45
Ex-dividend date
23 Jul. 2026
P/E ratio
10,96
52-wk high
NT$60,55
52-wk low
NT$48,64
EPS
NT$5,10
Shares outstanding
178,70 m
No. of employees
1 k
Open
NT$55,70
High
NT$56,20
Low
NT$55,70
Mkt. cap
10,99 mjd
Avg. vol.
176,91 k
Volume
114,65 k
Dividend
3,25%
Quarterly dividend
NT$0,45
Ex-dividend date
23 Jul. 2026
P/E ratio
10,96
52-wk high
NT$60,55
52-wk low
NT$48,64
EPS
NT$5,10
Shares outstanding
178,70 m
No. of employees
1 k
News stories
From web sources and news partners
About Standard Chem & Pharm Co Ltd
CEO-
Employees1,13 k
Founded1967
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,77 mjd
1,79 mjd
1,65 mjd
1,87 mjd
Cost of goods sold
1,03 mjd
1,05 mjd
931,28 m
1,05 mjd
Cost of revenue
1,03 mjd
1,05 mjd
931,28 m
1,05 mjd
Research and development expenses
69,62 m
65,19 m
60,84 m
75,47 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
318,93 m
317,40 m
316,72 m
339,84 m
Operating expense
389,37 m
383,07 m
377,22 m
413,87 m
Total operating expenses
1,42 mjd
1,43 mjd
1,31 mjd
1,46 mjd
Operating income
347,98 m
352,95 m
343,37 m
407,85 m
Other non operating income
4,45 m
9,60 m
5,78 m
4,89 m
EBT including unusual items
483,62 m
394,83 m
375,26 m
436,10 m
EBT excluding unusual items
471,56 m
392,63 m
372,99 m
412,52 m
Income tax expense
75,22 m
79,96 m
76,67 m
74,60 m
Effective tax rate
15,55%
20,25%
20,43%
17,11%
Other operating expenses
-
-
-
-
Net income
307,60 m
229,21 m
231,52 m
258,60 m
Net profit margin
17,38%
12,84%
14,02%
13,81%
Earnings per share
1,56
-
-
-
Interest and investment income
97,83 m
10,69 m
7,76 m
13,75 m
Interest expense
-1,92 m
-2,95 m
-2,36 m
-2,38 m
Net interest expenses
95,91 m
7,74 m
5,41 m
11,37 m
Depreciation and amortization charges
-
-
-
-
EBITDA
449,88 m
455,88 m
445,31 m
507,17 m
Gain or loss from assets sale
816,00 k
61,00 k
3,12 m
53,00 k
AI content may include mistakes. Learn more
Google-programme